Inherited and somatic CD3ζ mutations in a patient with T-cell deficiency

New England Journal of Medicine

Volumn 354, Issue 18, 2006, Pages 1913-1921

  Rieux Laucat, Frédéric ^a,b,c   Hivroz, Claire ^d   Lim, Annick ^e   Mateo, Véronique ^a,b,c   Pellier, Isabelle ^b   Selz, Françoise ^a,b,c   Fischer, Alain ^a,b,c   Le Deist, Françoise ^f  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d INSTITUT CURIE   (France)

^e INSTITUT PASTEUR   (France)

^f UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD3ZETA ANTIGEN; IMMUNOGLOBULIN; LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; CD3 ANTIGEN, ZETA CHAIN; LYMPHOCYTE ANTIGEN RECEPTOR;

ANAMNESIS; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; CELL MATURATION; CLINICAL FEATURE; GERM LINE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; INFANT; LABORATORY DIAGNOSIS; LYMPHOCYTE FUNCTION; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SERODIAGNOSIS; SOMATIC MUTATION; T LYMPHOCYTE; TREATMENT OUTCOME; BLOOD; GENETICS; HOMOZYGOTE; IMMUNOLOGY; LYMPHOCYTE COUNT; METABOLISM; MUTATION; NUCLEOTIDE SEQUENCE;

ANTIGENS, CD3; BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; GERM-LINE MUTATION; HOMOZYGOTE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; LYMPHOCYTE COUNT; MALE; RECEPTOR-CD3 COMPLEX, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 33646378182     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa053750     Document Type: Article

References (35)

1. Call ME, Wucherpfennig KW. The T cell receptor: critical role of the membrane environment in receptor assembly and function. Annu Rev Immunol 2005;23:101-25.
2. Sussman JJ, Bonifacino JS, Lippincott-Schwartz J, et al. Failure to synthesize the T cell CD3-zeta chain: structure and function of a partial T cell receptor complex. Cell 1988;52:85-95.
3. Irving BA, Chan AC, Weiss A. Functional characterization of a signal transducing motif present in the T cell antigen receptor zeta chain. J Exp Med 1993;177:1093-103.
4. Chan AC, Iwashima M, Turck CW, Weiss A. ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR zeta chain. Cell 1992;71:649-62.
5. Liu CP, Ueda R, She J, et al. Abnormal T cell development in CD3-zeta-/- mutant mice and identification of a novel T cell population in the intestine. EMBO J 1993;12:4863-75.
6. Love PE, Shores EW, Johnson MD, et al. T cell development in mice that lack the zeta chain of the T cell antigen receptor complex. Science 1993;261:918-21.
7. Malissen M, Gillet A, Rocha B, et al. T cell development in mice lacking the CD3-zeta/eta gene. EMBO J 1993;12:4347-55.
8. Ohno H, Aoe T, Taki S, et al. Developmental and functional impairment of T cells in mice lacking CD3 zeta chains. EMBO J 1993;12:4357-66.
9. Fischer A. Human primary immunodeficiency diseases: a perspective. Nat Immunol 2004;5:23-30.
10. Puel A, Ziegler SF, Buckley RH, Leonard WJ. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet 1998;20:394-7.
11. Kung C, Pingel JT, Heikinheimo M, et al. Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease. Nat Med 2000;6:343-5.
12. Tchilian EZ, Wallace DL, Wells RS, Flower DR, Morgan G, Beverley PC. A deletion in the gene encoding the CD45 antigen in a patient with SCID. J Immunol 2001;166:1308-13.
13. Dadi HK, Simon AJ, Roifman CM. Effect of CD3δ deficiency on maturation of α/β and γ/δ T cell lineages in severe combined immunodeficiency. N Engl J Med 2003;349:1821-8. [Erratum, N Engl J Med 2004;350:1803.]
14. de Saint Basile G, Geissmann F, Flori E, et al. Severe combined immunodeficiency caused by deficiency in either the delta or the epsilon subunit of CD3. J Clin Invest 2004;114:1512-7.
15. Andre-Schmutz I, Le Deist F, Hacein-Bey S, et al. Donor T lymphocyte infusion following ex vivo depletion of donor anti-host reactivity by a specific anti-interleukin-2 receptor P55 chain immunotoxin. Transplant Proc 2002;34:2927-8.
16. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000;288:669-72.
17. Pannetier C, Levraud A, Lim A, Even J, Kourilsky P. The Immunoscope approach for analysis of TcR repertoire. In: Oksenberg JR, ed. The antigen T cell receptor: selected protocols and application. Austin, Tex.: R.G. Landes, 1997:287.
18. Lim A, Baron V, Ferradini L, Bonneville M, Kourilsky P, Pannetier C. Combination of MHC-peptide multimer-based T cell sorting with the Immunoscope permits sensitive ex vivo quantitation and follow-up of human CD8+ T cell immune responses. J Immunol Methods 2002;261:177-94.
19. Dumont C, Blanchard N, Di Bartolo V, et al. TCR/CD3 down-modulation and zeta degradation are regulated by ZAP-70. J Immunol 2002;169:1705-12.
20. Bonnerot C, Briken V, Brachet V, et al. syk Protein tyrosine kinase regulates Fc receptor gamma-chain-mediated transport to lysosomes. EMBO J 1998;17:4606-16.
21. Rieux-Laucat F, Blachere S, Danielan S, et al. Lymphoproliferative syndrome with autoimmunity: a possible genetic basis for dominant expression of the clinical manifestations. Blood 1999;94:2575-82.
22. Guy-Grand D, Rocha B, Mintz P, et al. Different use of T cell receptor transducing modules in two populations of gut intraepithelial lymphocytes are related to distinct pathways of T cell differentiation. J Exp Med 1994;180:673-9.
23. Weissman AM, Frank SJ, Orloff DG, Mercep M, Ashwell JD, Klausner RD. Role of the zeta chain in the expression of the T cell antigen receptor: genetic reconstitution studies. EMBO J 1989;8:3651-6.
24. Lin SY, Ardouin L, Gillet A, Malissen M, Malissen B. The single positive T cells found in CD3-zeta/eta-/- mice overtly react with self-major histocompatibility complex molecules upon restoration of normal surface density of T cell receptor-CD3 complex. J Exp Med 1997;185:707-15.
25. Arnaiz-Villena A, Timon M, Corell A, Perez-Aciego P, Martin-Villa JM, Regueiro JR. Primary immunodeficiency caused by mutations in the gene encoding the CD3-γ subunit of the T-lymphocyte receptor. N Engl J Med 1992;327:529-33.
26. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005;6:345-52.
27. Hirschhorn R, Yang DR, Israni A, Huie ML, Ownby DR. Somatic mosaicism for a newly identified splice-site mutation in a patient with adenosine deaminase-deficient immunodeficiency and spontaneous clinical recovery. Am J Hum Genet 1994;55:59-68.
28. Hirschhorn R, Yang DR, Puck JM, Huie ML, Jiang CK, Kurlandsky LE. Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency. Nat Genet 1996;13:290-5.
29. Arredondo-Vega FX, Santisteban I, Richard E, et al. Adenosine deaminase deficiency with mosaicism for a "second-site suppressor" of a splicing mutation: decline in revertant T lymphocytes during enzyme replacement therapy. Blood 2002;99:1005-13.
30. Stephan V, Wahn V, Le Deist F, et al. Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells. N Engl J Med 1996;335:1563-7.
31. Wada T, Toma T, Okamoto H, et al. Oligoclonal expansion of T lymphocytes with multiple second-site mutations leads to Omenn syndrome in a patient with RAG1-deficient severe combined immunodeficiency. Blood 2005;106:2099-101.
32. Wada T, Schurman SH, Otsu M, et al. Somatic mosaicism in Wiskott-Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism. Proc Natl Acad Sci U S A 2001;98:8697-702.
33. Ariga T, Kondoh T, Yamaguchi K, et al. Spontaneous in vivo reversion of an inherited mutation in the Wiskott-Aldrich syndrome. J Immunol 2001;166:5245-9.
34. Ariga T, Yamada M, Sakiyama Y, Tatsuzawa O. A case of Wiskott-Aldrich syndrome with dual mutations in exon 10 of the WASP gene: an additional de novo one-base insertion, which restores frame shift due to an inherent one-base deletion, detected in the major population of the patient's peripheral blood lymphocytes. Blood 1998;92:699-701.
35. Nishikomori R, Akutagawa H, Maruyama K, et al. X-linked ectodermal dysplasia and immunodeficiency caused by reversion mosaicism of NEMO reveals a critical role for NEMO in human T cell development and/or survival. Blood 2004;103:4565-72.